Provided by Tiger Trade Technology Pte. Ltd.

Yesterday's Top Gainers

730.33
-6.0197-0.82%
Number of Gainers:18
Number of Losers:30
Number of Flat:5
PE:- -
High:736.38
Open:736.25
Low:730.33
Close:736.37
Volume:27.95M
Turnover:331.95M
Market Cap:123.20B
Float Cap:76.44B

Loading ...

RELX Expands Treasury Stock with Further Share Buybacks

TIPRANKS
·
Sep 28

Global Oil Prices Open Higher While Gold and Silver Fall Together

Deep News
·
Sep 28

Li Auto Weibo Lucky Draw Winner Announced: Luo Yonghao Wins iPhone 17 Pro Max, Netizens Joke They Thought It Was Photoshopped

Deep News
·
Sep 26

Mohawk is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Sep 25

Asian Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Down for Week

MT Newswires Live
·
Sep 25

Li Auto Accused of Copying Volvo Ad as Volvo China Responds: Some Classics Are Remembered Each Time They Are Revisited

Deep News
·
Sep 25

Ocugen Shares Rise on Provisional Approval for Retinitis Pigmentosa Treatment in Bahamas

Dow Jones
·
Sep 25

Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX) and Resmed (RMD)

TIPRANKS
·
Sep 25

3 Australian Hidden Gem Stocks With Up To 83% Fair Value Upside

Simply Wall St.
·
Sep 25

Ocugen Wins Provisional Approval for Ocu400 in Bahamas Under LARTA Pathway

Reuters
·
Sep 25

Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in the Bahamas to Provide Ocu400 to Patients for Treatment of Retinitis Pigmentosa

THOMSON REUTERS
·
Sep 25

Bilibili Sets Record Dates Ahead of October 28 EGM on Off-Market Share Buy-Back

TIPRANKS
·
Sep 25

Bilibili Inc. to Hold Extraordinary General Meeting on October 28, 2026

GlobeNewswire
·
Sep 25

Here's How to Position Your Portfolio for the Next AI Wave, According to Morgan Stanley

Dow Jones
·
Sep 25

Avacta Group plc: The FOCUS-01 Clinical Trial Design and Preclinical Data Further Demonstrate the Potential of AVA6103 at AACR Conference on Pancreatic Cancer

GlobeNewswire
·
Sep 25

US and Iran Said to Explore Phased Deal to Reopen Strait of Hormuz as Oil Prices Edge Lower

Stock News
·
Sep 25

Regenxbio presents positive 3-year durability data for Surabgene Lomparvove

TIPRANKS
·
Sep 25

Regenxbio Reports 3-Year Durability Data for Sura-Vec in Phase II Altitude Diabetic Retinopathy Trial

Reuters
·
Sep 25

EDU Holdings Updates Market on Progress of On-Market Share Buy-Back

TIPRANKS
·
Sep 25

Pedevco to Present at Lytham Partners Virtual Investor Conference

Reuters
·
Sep 25